Antioxidant pill tested to sharpen minds in schizophrenia
NCT ID NCT06191965
Summary
This study is testing if a daily antioxidant supplement called MitoQ can improve thinking skills like memory and focus in people with early schizophrenia. Researchers will enroll 100 people, but only 50 with a specific blood marker will take either MitoQ or a placebo pill for 12 weeks alongside their regular medications. The main goal is to see if the supplement helps with cognitive problems that currently have no effective treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
McLean Hospital
RECRUITINGBelmont, Massachusetts, 02478, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Lausanne
NOT_YET_RECRUITINGLausanne, Switzerland
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Yale School of Medicine
NOT_YET_RECRUITINGNew Haven, Connecticut, 06519, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.